Browsing by Author "Amano, Shinya U."

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice
    (Proceedings of the National Academy of Sciences, 2013) Aouadi, Myriam; Tencerova, Michaela; Vangala, Pranitha; Yawe, Joseph C.; Amano, Shinya U.; Czech, Michael P.
    Adipose tissue (AT) inflammation and infiltration by macrophages is associated with insulin resistance and type 2 diabetes in obese humans, offering a potential target for therapeutics. However, whether AT macrophages (ATMs) directly contribute to systemic glucose intolerance has not been determined. The reason is the lack of methods to ablate inflammatory genes expressed in macrophages specifically localized within AT depots, leaving macrophages in other tissues unaffected. Here we report that i.p. administration of siRNA encapsulated by glucan shells in obese mice selectively silences genes in epididymal ATMs, whereas macrophages within lung, spleen, kidney, heart, skeletal muscle, subcutaneous (SubQ) adipose, and liver are not targeted. Such administration of GeRPs to silence the inflammatory cytokines TNF-α or osteopontin in epididymal ATMs of obese mice caused significant improvement in glucose tolerance. These data are consistent with the hypothesis that cytokines produced by ATMs can exacerbate whole-body glucose intolerance.
  • Thumbnail Image
    Item
    Local Proliferation of Macrophages Contributes to Obesity-Associated Adipose Tissue Inflammation
    (Cell metabolism, 2014) Amano, Shinya U.; Cohen, Jessica L.; Vangala, Pranitha; Tencerova, Michaela; Nicoloro, Sarah M.; Yawe, Joseph C.; Czech, Michael P.; Aouadi, Myriam
    Adipose tissue (AT) of obese mice and humans accumulates immune cells, which secrete cytokines that can promote insulin resistance. AT macrophages (ATMs) are thought to originate from bone-marrow-derived monocytes, which infiltrate the tissue from the circulation. Here, we show that a major fraction of macrophages unexpectedly undergo cell division locally within AT, as detected by Ki67 expression and 5-ethynyl-2′-deoxyuridine incorporation. Macrophages within the visceral AT (VAT), but not those in other tissues (including liver and spleen), displayed increased proliferation in obesity. Importantly, depletion of blood monocytes had no impact on ATM content, whereas their proliferation in situ continued. Treatment with monocyte chemotactic protein 1 (MCP-1) induced macrophage cell division in AT explants, whereas mcp-1 deficiency in vivo decreased ATM proliferation. These results reveal that, in addition to blood monocyte recruitment, in situ proliferation driven by MCP-1 is an important process by which macrophages accumulate in the VAT in obesity.